Back to search
Encephalopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Encephalopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Encephalopathy trials you may qualify forThe goal of this clinical trial is to learn if administration of plasma, from a whole blood donation from an individual who has declared a Chikungunya infection…
The purpose of the study is to evaluate the efficacy, safety, and tolerability of zorevunersen in Patients with Dravet syndrome.
The Metabolism, Infection and Immunity (MINI) Study is a longitudinal natural history study at the National Institutes of Health (NIH) that aims to define the r…
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with mild HIE. To determine the adverse effects of Therapeutic Hypotherm…
Newborns with mild hypoxic-ischemic encephalopathy usually do not receive cooling treatment. However, some of these newborns may develop neurological problems l…
This is an observational study in patients who require clinical anesthesia. The main purpose of this study is to understand whether there are differences in the…
This retrospective observational cohort study aims to identify early predictors of short- and mid-term mortality in adult patients who achieved return of sponta…
The aim of this pilot study is to explore whether the knowledge and experience gained during the T-GaiD project (Treatment of Gait Disorders in Dravet Syndrome…
This is a Phase 1, first-in-human (FIH) safety, proof-of-concept, two-part study of the genetically-engineered EGEN-5784 liver in combination with the metra® ex…